BR9006793A - Composicao,composicao de gel e processo para o tratamento intravaginal de vaginites e composicao acidificadora vaginal - Google Patents

Composicao,composicao de gel e processo para o tratamento intravaginal de vaginites e composicao acidificadora vaginal

Info

Publication number
BR9006793A
BR9006793A BR909006793A BR9006793A BR9006793A BR 9006793 A BR9006793 A BR 9006793A BR 909006793 A BR909006793 A BR 909006793A BR 9006793 A BR9006793 A BR 9006793A BR 9006793 A BR9006793 A BR 9006793A
Authority
BR
Brazil
Prior art keywords
composition
vaginites
vaginal
acidifying
metronidazole
Prior art date
Application number
BR909006793A
Other languages
English (en)
Inventor
Robert J Borgman
Original Assignee
Curatek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curatek Pharmaceuticals filed Critical Curatek Pharmaceuticals
Publication of BR9006793A publication Critical patent/BR9006793A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR909006793A 1989-06-06 1990-06-04 Composicao,composicao de gel e processo para o tratamento intravaginal de vaginites e composicao acidificadora vaginal BR9006793A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36227389A 1989-06-06 1989-06-06
PCT/US1990/003195 WO1990014832A1 (en) 1989-06-06 1990-06-04 Improved intravaginal treatment of vaginal infections with buffered metronidazole compositions

Publications (1)

Publication Number Publication Date
BR9006793A true BR9006793A (pt) 1991-08-06

Family

ID=23425444

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909006793A BR9006793A (pt) 1989-06-06 1990-06-04 Composicao,composicao de gel e processo para o tratamento intravaginal de vaginites e composicao acidificadora vaginal

Country Status (21)

Country Link
EP (1) EP0404376B1 (pt)
JP (1) JP2999820B2 (pt)
KR (1) KR0169487B1 (pt)
CN (1) CN1054507C (pt)
AT (1) ATE103176T1 (pt)
AU (1) AU635752B2 (pt)
BR (1) BR9006793A (pt)
CA (1) CA1337279C (pt)
DE (1) DE69007547T2 (pt)
DK (1) DK0404376T3 (pt)
ES (1) ES2062366T3 (pt)
HU (1) HU207795B (pt)
IE (1) IE65413B1 (pt)
IL (1) IL94619A (pt)
PH (1) PH30718A (pt)
PL (1) PL164128B1 (pt)
RO (1) RO109156B1 (pt)
RU (1) RU2032402C1 (pt)
WO (1) WO1990014832A1 (pt)
YU (1) YU47950B (pt)
ZA (1) ZA904413B (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
NZ528377A (en) * 2001-03-27 2005-05-27 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
GB0130666D0 (en) * 2001-12-21 2002-02-06 Accantla Holdings Ltd Absorbent tampons
US6899890B2 (en) 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US7417013B2 (en) 2002-05-01 2008-08-26 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
BRPI0309765B8 (pt) * 2002-05-01 2021-05-25 Mcneil Ppc Inc composições em gel antifúngicas lubrificantes não-irritantes e aquecedoras
KR101046538B1 (ko) * 2002-05-01 2011-07-07 맥네일-피피씨, 인코포레이티드 가온성 및 비자극성 무수 윤활제 조성물
US7658941B2 (en) 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7005408B2 (en) 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7695730B2 (en) 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US9241997B2 (en) * 2003-06-13 2016-01-26 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
BRPI0414500A (pt) * 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
US7851419B2 (en) 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
AU2006332520A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
EP1968543A2 (en) * 2006-01-05 2008-09-17 Drugtech Corporation Composition and method of use thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EP2385821B1 (en) * 2009-01-09 2016-08-31 Egis Gyógyszergyár Zrt. Improved pharmaceutical formulation
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
BR112013033759B1 (pt) 2011-06-28 2021-05-25 Chemo Research Sl forma de dosagem unitária de um gel de base aquosa de metronidazol mucoadesivo e uso relacionado ao gel de base aquosa de metronidazol
CA2916002A1 (en) 2013-06-25 2014-12-31 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
RU2730021C1 (ru) * 2019-10-08 2020-08-14 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Средство местного применения для лечения инфекционных вагинитов
CN112773780A (zh) * 2019-11-11 2021-05-11 深圳优丽康生物技术有限公司 一种阴道外阴用组合物及其用途
RU2726123C1 (ru) * 2019-12-20 2020-07-09 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Способ лечения трихомониаза у женщин
CA3184425A1 (en) * 2020-06-30 2022-01-06 Mark C. Faulkner Compositions for controlling odor and itch and methods of and devices for administering same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan

Also Published As

Publication number Publication date
EP0404376A3 (en) 1991-06-05
IE65413B1 (en) 1995-10-18
CA1337279C (en) 1995-10-10
WO1990014832A1 (en) 1990-12-13
EP0404376A2 (en) 1990-12-27
AU5829490A (en) 1991-01-07
KR0169487B1 (ko) 1999-01-15
PL285507A1 (en) 1992-01-13
RU2032402C1 (ru) 1995-04-10
CN1049101A (zh) 1991-02-13
PL164128B1 (pl) 1994-06-30
IE902011L (en) 1990-12-06
DK0404376T3 (da) 1994-05-24
KR920700032A (ko) 1992-02-19
IL94619A (en) 1995-01-24
ES2062366T3 (es) 1994-12-16
EP0404376B1 (en) 1994-03-23
YU47950B (sh) 1996-07-24
YU170090A (sh) 1994-04-05
IL94619A0 (en) 1991-04-15
HU904720D0 (en) 1991-07-29
AU635752B2 (en) 1993-04-01
RO109156B1 (ro) 1994-12-30
JP2999820B2 (ja) 2000-01-17
ZA904413B (en) 1991-04-24
CN1054507C (zh) 2000-07-19
JPH04500365A (ja) 1992-01-23
HUT56490A (en) 1991-09-30
DE69007547D1 (de) 1994-04-28
ATE103176T1 (de) 1994-04-15
DE69007547T2 (de) 1994-07-14
HU207795B (en) 1993-06-28
PH30718A (en) 1997-09-23

Similar Documents

Publication Publication Date Title
BR9006793A (pt) Composicao,composicao de gel e processo para o tratamento intravaginal de vaginites e composicao acidificadora vaginal
DE69025943D1 (de) Verwendung von Spiperone-derivate zur Immunosuppression
IE812025L (en) Composition for treating osteitis
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
EP0266968A3 (en) Gelled ointment of vasodilating agent
ES2029853T3 (es) Un metodo para preparar una base para pomada de gel.
ATE60998T1 (de) Augengel sowie verfahren zu dessen herstellung.
DK0621038T3 (da) Farmaceutiske præparater indeholdende silikatpolymere
FI954804A0 (fi) Ioneenipolymeerit matolääkkeinä eläimillä
CN113999406A (zh) 一种多功能抗菌水凝胶敷料的制备方法及应用
DE3773383D1 (de) Neue topische metronidazol-formulierungen.
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
KR870002254A (ko) 요로 감염치료용 백신의 제조방법
HU901897D0 (en) Process for producing medical preparations suitable for treating vaginal infection
ES8705900A1 (es) Procedimiento para producir un polimero de formacion de hi- drogel
ATE50586T1 (de) Absorbierendes polymeres material und dessen herstellung.
FR2742336B1 (fr) Collyre destine notamment au traitement de l'oeil sec
FR2648458B1 (fr) Acide diallyloxyacetique et ses sels d'addition basiques, leur procede de preparation et leur application comme agent reticulant
IT1234738B (it) Procedimento per l'ottenimento di un biopolimero reticolato a base di collagene, impianto a base di questo biopolimero e procedimento per l'ottenimento dell'impianto.
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя
SE8901958D0 (sv) Foerfarande foer framstaellning av en biologisk foernaetad, kollagenbaserad biopolymer, fraan denna framstaellt implantat och foerfarande foer framstaellning av implantatet
UA39654C2 (uk) Спосіб дренування гнійних ран

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
PC Transfer

Free format text: MINNESOTA MINING AND MANUFACTURING COMPANY (US)

FC Decision: refusal
CKFC Appeal: appeal against refusal